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Abstract
Background: Pneumonia and malaria are the leading causes of global childhood
mortality. We describe the clinical presentation of children diagnosed with pneu-
monia and/or malaria, and identify possible missed cases and diagnostic predictors.
Methods: Prospective cohort study involving children (aged 28 days to 15 years)
admitted to 12 secondary‐level hospitals in south‐west Nigeria, from November
2015 to October 2017. We described children diagnosed with malaria and/or
pneumonia on admission and identified potential missed cases using WHO criteria.
We used logistic regression models to identify associations between clinical features
and severe pneumonia and malaria diagnoses.
Results: Of 16 432 admitted children, 16 184 (98.5%) had adequate data for ana-
lysis. Two‐thirds (10 561, 65.4%) of children were diagnosed with malaria and/or
pneumonia by the admitting doctor; 31.5% (567/1799) of those with pneumonia
were also diagnosed with malaria. Of 1345 (8.3%) children who met WHO severe
pneumonia criteria, 557 (41.4%) lacked a pneumonia diagnosis. Compared with
“potential missed” diagnoses of severe pneumonia, children with “detected” severe
pneumonia were more likely to receive antibiotics (odds ratio [OR], 4.03; 2.63‐6.16,
P < .001), and less likely to die (OR, 0.72; 0.51‐1.02, P = .067). Of 2299 (14.2%)
children who met WHO severe malaria criteria, 365 (15.9%) lacked a malaria di-
agnosis. Compared with “potential missed” diagnoses of severe malaria, children
with “detected” severe malaria were less likely to die (OR, 0.59; 0.38‐0.91,
P = 0.017), with no observed difference in antimalarial administration (OR, 0.29; 0.87
‐1.93, P = .374). We identified predictors of severe pneumonia and malaria diagnosis.
Conclusion: Pneumonia should be considered in all severely unwell children with
respiratory signs, regardless of treatment for malaria or other conditions.
K E YWORD S
Africa, child, diagnosis, infections: pneumonia, TB, viral, International Health, malaria, Nigeria
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals, Inc.
1 | INTRODUCTION
Pneumonia and malaria are the leading causes of global mortality in
children under 5 years.1 In 2017, pneumonia and malaria accounted
for almost one‐third of deaths in children under 5 years (excluding
the neonatal period).1 The majority of pneumonia and malaria cases
and deaths occur in low‐ and middle‐income countries, with parti-
cularly high burden in sub‐Saharan Africa.1,2 In 2017, the WHO
Africa region recorded 426 000 pneumonia deaths and 257 000
malaria deaths among children under 5 years of age.1 This accounted
for 53% of global pneumonia deaths, and 98% of global malaria
deaths, for children under 5 years of age during that year.1
World Health Organisation (WHO) guidelines recommend a case
management approach to the diagnosis and management of pneu-
monia and malaria.3,4 However, the clinical presentation of pneumonia
and malaria can be similar, involving fever, fast breathing, and other
signs of severe illness such as altered conscious state.4 Previous re-
ports have highlighted the risks of under and overdiagnosis of pneu-
monia and malaria, recommending that, in malaria‐endemic regions,
children with a positive malaria test and respiratory signs who require
hospitalization should be treated for both pneumonia and malaria.5,6
However, we have few data on the clinical overlap of pneumonia and
malaria syndromes, or current diagnostic practices, among hospitalized
children in high‐burden countries such as Nigeria.5‐7
Nigeria is a populous lower‐middle‐income country in west
Africa with high child and neonatal mortality (2017: under‐five
mortality 100, neonatal mortality 33, per 1000 live births).8 Pneu-
monia and malaria are the major causes of child deaths, accounting
for 18% and 14% of deaths, respectively.8 Recent estimates show
that Nigeria contributed one‐quarter of under‐five malaria deaths
and one‐sixth of under‐five pneumonia deaths globally in 2017.1
The aim of this study was to describe the clinical presentation of
children diagnosed with pneumonia and/or malaria at secondary‐
level hospitals in Nigeria and to explore clinical decision making at
the point of admission. Our exploratory analysis identified potential
missed cases of severe pneumonia and severe malaria, explored
predictors of “correct” pneumonia and malaria admission diagnoses,
and considered reasons for clinical overlap and alternative diagnoses
in malaria and pneumonia syndromes.
2 | METHODS
2.1 | Design
We conducted a prospective cohort study nested within a stepped‐
wedge trial evaluating pulse oximetry and oxygen systems in 12
Nigerian hospitals.9 The study design has been described previously.9
In brief, it involved (a) baseline needs assessment and retrospective
clinical review, (b) introduction of pulse oximetry to all participating
hospitals (November 2015), and (c) stepped introduction of a
comprehensive oxygen system, with hospitals randomized to receive
the intervention between March 2016 and March 2017.9 We have
previously reported results from our needs assessment,10,11 process
evaluation,12,13 and impact evaluation.14 This paper reports an ex-
ploratory secondary analysis using prospective data from November
2015 to October 2017 extracted from clinical records.
2.2 | Participants
We conducted this study in southwest Nigeria, recruiting 12 small‐ to
medium‐sized hospitals that were representative of secondary
healthcare facilities that admit children.9 We included government
(n = 7) and mission (n = 5) hospitals of varying capacity (Table 1, more
details in Appendix 1). All hospitals were low‐altitude (elevation
50‐500 m above sea level) and in malaria‐endemic regions. Pediatric
care was provided by junior doctors and generalist nurses under the
supervision of family medicine physicians and/or pediatricians
(Table 1). Patients requiring additional medical services were
referred to larger secondary‐ or tertiary‐level hospitals.
We included all children aged 28 days to 15 years who were
admitted to participating hospitals during the study period (Table 1).
2.3 | Materials and procedures
Trained research nurses used standardized data collection forms to
gather data from clinical records immediately following patient dis-
charge. Documented data included participant demographics, signs
and symptoms on admission, admission diagnoses, and clinical care
practices. Admission documentation was typically performed by ju-
nior doctors (medical admission note) and generalist nurses (nursing
observations and nursing admission note). Admitting doctors were
typically junior doctors who did not have pediatric specialty training,
who performed their pediatric clinical duties while also covering
other wards, and who would complete admission documentation at
the point of admission (outpatient or emergency department) or on
the pediatric ward. Admitting nurses were typically generalist nurses
or nursing assistants who were based on the pediatric ward and who
would complete admission documentation when the child arrived on
the ward.
As part of our broader pulse oximetry and oxygen intervention,9
we trained doctors and nurses on pulse oximetry and oxygen ther-
apy, in accordance with WHO guidelines.15 We did not provide
doctors or nurses with additional training or standardization of di-
agnostic, treatment, or documentation practices. We did not provide
any pneumonia‐ or malaria‐specific training or guidance.
2.4 | Data analysis
Trained data entry clerks used EpiData 3.116 to double‐enter data
from data collection forms following standard data management
procedures. We performed data cleaning and analysis using
Stata 15.1.17
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We identified children diagnosed with pneumonia or malaria on
admission, permitting multiple diagnoses. We accepted all diagnostic
terms relating to lower respiratory tract infection for pneumonia
(including bronchiolitis) and similarly for malaria. We categorized
participant diagnoses as “malaria,” “malaria + pneumonia,” “pneumo-
nia,” or “neither malaria nor pneumonia.” For each category, we
summarized demographic and clinical symptoms and signs using de-
scriptive statistics and tests of difference. We summarized catego-
rical variables by number and percentages. We summarized
continuous variables by mean and standard deviation (SD) if normally
distributed, and by median and interquartile range (25th and 75th
centiles) if non‐normally distributed. We used χ2 test to evaluate
differences between categorical dependent and independent vari-
ables, t test for dichotomous independent variables on a continuous
outcome, and analysis of variance for multiple categorical in-
dependent variables on a continuous outcome.
Using WHO case definitions (Box 1), we identified the number of
children who met clinical criteria for severe pneumonia or severe ma-
laria diagnosis4 in each of the admission diagnosis subgroups. These
WHO case definitions are not “gold standard” classifications for severe
pneumonia or malaria. Rather, they are clinical syndromes that are in-
tended to guide the assessment, diagnosis, and treatment of severely ill
children with conditions that are major causes of childhood mortality.4
As described in the WHO Pocketbook of Hospital Care for Children, these
WHO clinical case definitions are intended for use by generalist doctors
and nurses working at first‐referral level health hospitals with limited
diagnostic capacity.WHO Pocketbook diagnostic and treatment advice is
consistent with Nigeria's Standard Treatment Guidelines (but provides
additional specific advice for the pediatric population)18 and WHO
primary care guidelines (integrated management of childhood illness).4
Both the admission diagnosis and the clinical case definition
classifications were derived from the admitting doctor and nurse's
documentation at the time of admission. If a clinical sign was not
recorded, we assumed that it was not present.
By focusing on admission diagnoses and clinical case definitions,
we were able to explore real‐life diagnostic and management prac-
tices in the critical first hours of a severely ill child presenting to
hospital. We categorized those meeting WHO criteria for severe
pneumonia as “detected” or “potential missed” depending on whether
they had a corresponding admission diagnosis of pneumonia. We
categorized those meeting WHO criteria for malaria similarly.
To understand diagnostic decision making, we compared “de-
tected” vs “potential missed” severe pneumonia subgroups. We built
univariate logistic regression models to look for associations between
presenting demographic characteristics, clinical signs, investigations,
treatment, and clinical outcomes, with a “detected” pneumonia and
malaria diagnosis. We then used a mixed effects logistic regression
model to evaluate the relative contribution of demographic char-
acteristics, clinical signs, and investigations to pneumonia and malaria
diagnostic status (“detected” vs “potential missed”). We selected
variables for inclusion in the multivariate model using backward and
forward stepwise regression. We used random effects to adjust for
clustering at the hospital level.
We report odds ratios (ORs), adjusted odds ratios (aORs), and
95% confidence intervals (95% CI) using complete case analysis ap-
proach (ie, dropping missing data from analysis).19
3 | RESULTS
In the 24‐month study period (November 2015 to October 2017),
16 432 children were admitted to participating hospitals. Case notes
were available for 16 184 participants (98.5%) (Figure 1).
3.1 | Admission diagnoses
Two‐thirds (10 561, 65.4%) of admitted children had an admission
diagnosis of malaria and/or pneumonia (Figure 1). Of these, 9329
(88.3%) were diagnosed with malaria and 1799 (17.0%) were diag-
nosed with pneumonia, including 567 (5.4%) who were diagnosed
with both malaria and pneumonia. One‐third of those diagnosed with
pneumonia were also diagnosed with malaria (567/1799, 31.5%).
3.2 | Characteristics of children diagnosed with
pneumonia and malaria
Children diagnosed with pneumonia were younger than those with
malaria or other diagnoses (median age 9.8 vs 26 and 18 months,
P < .001) (Table 2). Most children presented with a history of fever
(13 144, 80.0%), while children diagnosed with malaria tended to
have higher admission temperature than those without
Box 1 Clinical case definitions for severe
pneumonia and severe malaria, derived from the
WHO Pocketbook of Hospital Care for Children.4
Severe pneumonia
Cough or Difficult breathing AND at least one of the
following:
• severe respiratory distress;
• hypoxemia (SpO2<90%);
• unable to breastfeed or drink adequately;
• decreased conscious state;
• seizures.
Severe malaria
Fever (or history of fever) AND positive malaria test (blood
film or rapid diagnostic test) AND at least one of the following:
• severe anemia;
• decreased conscious state;
• seizures.
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(37.8 vs 37.4°C, P < .001). Children diagnosed with pneumonia were
more likely to have cough or difficult breathing (86.4% vs 19.6%,
P < .001) and severe respiratory distress (39.8% vs 4.7%, P < .001)
than those diagnosed with malaria. They also tended to have a higher
respiratory rate (53.4 vs 37.2, P < .001) and were more likely to have
hypoxemia (31.2% vs 7.3%, P < .001). Children diagnosed with ma-
laria were more likely to have seizures (16.9% vs 3.3%, P < .001),
altered conscious state (7.9% vs 3.0%, P < .001), and signs of severe
dehydration (2.8% vs 0.5%, P < .001) than those diagnosed with
pneumonia.
Most children were tested for anemia (14 301, 88.4%) and
malaria (12 879, 79.6%) (Table 2). Approximately half the children
tested for anemia had low packed cell volume (PCV) (8317 of
14 301, 58.2%), and severe anemia (PCV < 15%) was more com-
mon among those diagnosed with malaria than pneumonia (11.8%
vs 1.1%, P < .001). HIV prevalence was low (<1% of admissions).
Chest X‐ray radiography was performed infrequently (242, 1.5%),
even among those diagnosed with pneumonia (196 of
1799, 10.9%).
Children diagnosed with pneumonia were more likely to die (6.5%
vs 3.1%, P < .001) or be transferred to another facility (3.7% vs 2.0%,
P < .001) compared with those diagnosed with malaria (Table 2).
3.3 | Severe pneumonia
Of all admitted children, 1345 (8.3%) met the WHO case definition
for severe pneumonia (Figure 1, Table 2). Of these, 557 (41.4%) did
not have pneumonia as an admission diagnosis, representing poten-
tial missed severe pneumonia diagnoses.
Compared with those with potential “missed” severe pneumonia
diagnoses, those with “detected” severe pneumonia were younger
(P < .001), more likely to have severe respiratory distress (aOR 3.87;
95% CI, 2.58‐5.79) and hypoxemia (aOR 2.01; 0.37‐2.96), less likely
to have diarrhea (aOR 0.29; 0.14‐0.63), feeding difficulty (aOR 0.59;
0.38‐0.90), seizures (aOR 0.26; 0.15‐0.44), confusion/lethargy (aOR
0.47; 0.27‐0.84), severe dehydration (aOR 0.09; 0.01‐0.53), positive
malaria test (aOR 0.49; 0.34‐0.71), or severe anemia (aOR 0.20; 0.09‐
0.45), and had lower admission temperature (aOR 0.78; 0.66‐0.92)
(Table 3).
Results from univariate logistic regression show that those with
“detected” severe pneumonia had greater odds of receiving parenteral
antibiotics on day 1 (OR, 4.03; 2.63‐6.16, P < .001; 95.9% vs 85.4%) and
lower odds of receiving intravenous fluids (OR, 0.63; 0.50‐0.81, P< .001;
66.4% vs 75.8%) compared with those with “potential missed” severe
pneumonia (Table 3). There was a negative association between mor-
tality and detected severe pneumonia; however, the 95% CI crossed the
null value (OR, 0.72; 0.51‐1.02, P = .067).
3.4 | Severe malaria
Of all admitted children, 2299 (14.2%) met the case definition for
severe malaria. Of these, 365 (15.9%) were not diagnosed with ma-
laria on admission, representing potential missed severe malaria
diagnoses.
F IGURE 1 Participant flow chart
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TABLE 2 Participant characteristics, comparing those with admission diagnoses of malaria, malaria‐pneumonia, pneumonia, or neither
malaria nor pneumonia
Characteristic
Malaria (not
pneumonia)
Malaria and
Pneumonia
Pneumonia
(not malaria)
Other (neither
malaria nor
pneumonia) Pa
Participants (total) 8762 (100) 567 (100) 1232 (100) 5623 (100)
Infants 28 d to 1 y 1777 (20.3) 239 (42.2) 686 (55.7) 1829 (32.5) <.001
Children 1‐4 y 4750 (54.2) 274 (48.3) 463 (37.6) 2444 (43.5) <.001
Children 5‐14 y 2185 (24.9) 50 (8.8) 77 (6.3) 1312 (23.3) <.001
Age unknown (missing) 50 (0.6) 4 (0.7) 6 (0.5) 38 (0.7) .337
Sex, female (%) 43.7 41.5 44.5 43.5 .694
Median age, months (IQR) 26.0 (12.5‐60.0) 15.0 (7.0‐26.6) 9.8 (3.6‐21.3) 18.4 (9.0‐53.7) <.001
Admission source: home vs other 8053 (92.6) 494 (88.4) 1114 (91.3) 5178 (92.9) <.001
Hospital type: government vs other 5356 (61.1) 313 (55.2) 842 (68.3) 3826 (38.0) <.001
Median LOS, days (IQR) 3 (2‐5) 4 (3.7) 4 (2‐7) 3 (2‐6) <.001
Documented signs and symptoms
History of fever 7979 (91.1) 504 (88.9) 868 (70.5) 3793 (67.5) <.001
History of cough or difficult breathing 1714 (19.6) 460 (81.1) 1064 (86.4) 992 (17.6) <.001
Severe respiratory distress 412 (4.7) 155 (27.3) 490 (39.8) 251 (4.5) <.001
Central cyanosis 57 (0.7) 3 (0.5) 11 (0.9) 23 (0.4) .108
Pallor 3222 (36.8) 130 (22.9) 194 (15.8) 1301 (23.1) <.001
Jaundice 354 (4.0) 8 (1.4) 14 (1.1) 213 (3.8) <.001
Diarrhea 999 (11.4) 33 (5.8) 39 (3.2) 989 (17.6) <.001
Feeding difficulty 1918 (21.9) 107 (18.9) 157 (12.7) 980 (17.4) <.001
Seizures 1481 (16.9) 55 (9.7) 41 (3.3) 503 (9.0) <.001
Confusion or lethargy 1131 (12.9) 41 (7.2) 60 (4.9) 578 (10.3) <.001
Unconscious or barely conscious 692 (7.9) 30 (5.3) 37 (3.0) 267 (4.8) <.001
Signs of shock 26 (0.3) 0 (0.0) 3 (0.24) 17 (0.3) .778
Severe dehydration 248 (2.8) 8 (1.4) 6 (0.5) 346 (6.2) <.001
Mean temperature, Celsius (SD) 37.8 (1.1) 37.8 (1.1) 37.4 (1.0) 37.4 (1.1) <.001
Mean heart rate, bpm (SD) 131.8 (24.8) 140.6 (25.6) 141.7 (26.3) 129.1 (24.9) <.001
Mean respiratory rate, bpm (SD) 37.2 (11.7) 49.0 (15.9) 53.4 (17.6) 36.7 (11.6) <.001
Median SpO2, % (IQR) 97 (95‐98) 95 (91‐98) 94 (87‐97) 97 (95‐98) <.001
Hypoxemia, SpO2<90% 501 (7.3) 105 (21.8) 332 (31.2) 359 (8.3) <.001
Investigations
PCV performed 8059 (92.0) 523 (92.2) 1036 (84.1) 4683 (83.3) <.001
Anemia 5047 (62.6) 296 (56.6) 509 (49.1) 2465 (52.6) <.001
Severe anemia 951 (11.8) 29 (5.5) 11 (1.1) 233 (5.0) <.001
Mean PCV, % (SD) 26.8 (8.9) 29.3 (7.5) 31.1 (5.8) 29.7 (7.7) <.001
Malaria test done 7456 (85.1) 496 (87.5) 927 (75.2) 4000 (71.1) <.001
RDT 3771 (43.0) 252 (44.4) 405 (32.9) 1764 (31.4) <.001
Microscopy 3723 (42.5) 247 (43.6) 527 (42.8) 2254 (40.1) .022
Malaria test positive 5002 (67.1) 256 (51.6) 255 (27.5) 1334 (33.4) <.001
RDT 2307 (61.2) 116 (46.0) 69 (17.0) 407 (23.1) <.001
Microscopy 2701 (72.6) 141 (57.1) 187 (35.5) 928 (41.2) <.001
HIV test done 2677 (30.6) 170 (30.0) 337 (27.4) 1648 (29.3) .089
HIV‐positive 28 (1.1) 5 (2.9) 9 (2.7) 41 (2.5) <.001
CXR performed 21 (0.2) 83 (14.6) 113 (9.2) 25 (0.4) <.001
CXR positiveb 12/13 (92.3) 59/70 (84.3) 81/100 (81.0) 13/19 (68.4) NA
Case definition diagnoses
Severe malaria 1881 (21.5) 53 (9.4) 25 (2.0) 340 (6.1) <.001
Severe pneumonia 349 (4.0) 212 (37.4) 576 (46.8) 208 (3.7) <.001
Other admission diagnoses
Diarrhea 1601 (18.3) 45 (7.9) 52 (4.2) 1680 (30.6) <.001
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Compared with those with potential “missed” severe malaria
diagnoses, those with “detected” severe malaria were more
likely to have a history of fever (aOR 3.78; 95% CI, 1.98‐7.23) and
anemia (aOR 0.40; 0.21‐0.74), and less likely to have a history
of cough or difficult breathing (aOR 0.71; 0.52‐0.97), severe
respiratory distress (aOR 0.60; 0.38‐0.93), diarrhea (aOR 0.33;
0.21‐0.50), and severe dehydration (aOR 0.40; 0.21‐0.74) (Table 4).
Antimalarial and intravenous fluid therapy were used frequently
(90.6% and 99.6%), and univariate logistic regression found no association
between children with missed versus detected severe malaria with regard
to antimalarial therapy (OR, 0.29; 0.87‐1.93, P= .209) (Table 4). There
was a negative association between mortality and detected severe ma-
laria (OR, 0.59; 95% CI, 0.38‐0.91, P= .017).
3.5 | Severe pneumonia and severe malaria
In total, 177 (1.2%) of children met WHO criteria for both severe
malaria and severe pneumonia, representing 7.7% (177/2299) of
those with severe malaria and 13.2% (177/1345) of those with
severe pneumonia (Figure 1).
4 | DISCUSSION
Pneumonia and malaria continue to be leading causes of mortality
in children in sub‐Saharan Africa. Using routinely collected
clinical data, this paper described children hospitalized with
malaria and pneumonia syndromes in a malaria‐endemic low‐
altitude region of southwest Nigeria. We identified “potential
missed” severe pneumonia and malaria cases, and explored as-
sociations between “detected” diagnosis and participant demo-
graphic, clinical signs, and investigations, to give insight into
current diagnostic practices.
We found that current diagnostic practices rely on clinical signs,
pulse oximetry, and malaria testing (microscopy or rapid diagnostic
testing, RDT), with little use of chest radiology. Almost half (557/
1345, 41%) of children presenting with documented evidence of
severe pneumonia (WHO case definition) were not given a pneu-
monia diagnosis. Compared with these “potential missed” diagnoses,
children with “detected” severe pneumonia were four times more
likely to receive parenteral antibiotics on day 1 of admission (OR,
4.03; 95% CI, 2.63‐6.16, P < .001), and showed a statistically non-
significant but clinically significant lower odds of death (OR, 0.72;
0.51‐1.02, P = .067).
In contrast, only 16% (365/2299) of children presenting with
evidence of severe malaria (WHO case definition) were not given a
malaria diagnosis. While there was no difference in the likelihood of
parenteral antimalarial administration between children with “po-
tential missed” and “detected” severe malaria (OR, 0.29; 0.87‐1.93,
P = .374), survival was better in those with a malaria diagnosis (OR,
0.59; 0.38‐0.91, P = .017). As a post hoc exploratory study, our
findings should be interpreted with caution; however, they raise
some interesting hypotheses.
TABLE 2 (Continued)
Characteristic
Malaria (not
pneumonia)
Malaria and
Pneumonia
Pneumonia
(not malaria)
Other (neither
malaria nor
pneumonia) Pa
Sepsis 2902 (33.1) 133 (23.5) 161 (13.1) 1896 (34.5) <.001
Seizures 841 (9.6) 25 (4.4) 25 (2.0) 403 (7.3) <.001
Haemoglobinopathy 310 (3.5) 6 (1.1) 11 (0.9) 403 (7.3) <.001
Meningitis/encephalitis 306 (3.5) 15 (2.7) 10 (0.8) 183 (3.3) <.001
Severe acute malnutrition 150 (1.7) 7 (1.2) 19 (1.5) 191 (3.5) <.001
Asthma 19 (0.2) 7 (1.2) 27 (2.2) 55 (1.0) <.001
Outcome
Discharged well 7720 (88.1) 483 (85.2) 1014 (82.3) 4707 (83.7) <.001
Died 269 (3.1) 30 (5.3) 80 (6.5) 263 (4.7) <.001
Discharged against medical advice 571 (6.5) 35 (6.2) 92 (7.5) 426 (7.5) .074
Transferred to other facility 170 (2.0) 18 (3.2) 45 (3.7) 209 (3.7) <.001
Missing data 32 (0.4) 1 (0.2) 1 (0.1) 18 (0.3) .374
Note: Number (%) unless otherwise indicated. Anemia = PCV < 32%. Died = died in hospital or palliated at home. Feeding difficulty, unable to
breastfeed or drink adequately. IQR = interquartile range, 25th to 50th centile. Severe anemia, PCV < 15%. Severe dehydration, sluggish capillary
refill time (>3 s), sunken eyes, decreased skin turgor. Severe malaria = fever or history of fever AND positive malaria test AND at least one of the
following: severe anemia; decreased conscious state; seizures. Severe pneumonia = cough or difficult breathing AND at least one of the following:
severe respiratory distress; hypoxemia (SpO2 < 90%); unable to breastfeed or drink adequately; decreased conscious state; seizures. Severe
respiratory distress = severe chest indrawing, grunting, gasping. Signs of shock = capillary refill < 3 s, weak pulse, low or unmeasurable blood
pressure.
Abbreviations: ANOVA, Analysis of variance; PCV, packed cell volume (hematocrit); SD, standard deviation.
aP values derived from χ2 or Fisher's exact test for categorical variables and t test or ANOVA for continuous independent variables.
bCXR denominator restricted to those with results available.
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TABLE 3 Associations with “detected” severe pneumonia diagnosis and presenting signs, treatments, and outcome
WHO severe pneumonia Odds ratio: detected severe pneumonia
Characteristic
“Potential
missed” diagnosis
“Detected”
diagnosis OR (95% CI) Pa aOR (95% CI)b P
Participants (total) 557 (100) 788 (100)
Infants 28 d to 1 y 168 (30.2) 452 (57.4) Reference …
Children 1‐4 y 306 (54.9) 296 (37.6) 0.36 (0.28‐0.46) <.001
Children 5‐14 y 81 (14.5) 36 (4.6) 0.17 (0.11‐0.25) <.001
Age unknown (missing) 2 (0.4) 4 (0.5) Not applicable
Sex, female (%) 44.3 45.3 0.96 (0.77‐1.20) .957 … …
Median age, (IQR) mo 19.0 (9.0‐36.0) 9.0 (3.4‐19.0) 0.98 (0.97‐0.98) <.001 0.98 (0.97‐0.98) <.001
Admission source: home vs other 497 (89.4) 701 (89.4) 1.00 (0.70‐1.43) .988 … …
Hospital type: government vs other 304 (54.6) 481 (61.0) 0.77 (0.62‐0.96) .018 … …
Median LOS, (IQR) d 4 (2‐6) 4 (2‐6) 1.05 (1.01‐1.08) .008 … …
Documented signs and symptoms
History of fever 479 (86.0) 585 (74.2) 0.47 (0.35‐0.63) <.001 … …
History of cough or difficult breathing 557 (100) 788 (100) Not applicable
Severe respiratory distress 240 (43.1) 573 (72.7) 3.52 (2.80‐4.43) <.001 3.87 (2.58‐5.79) <.001
Central cyanosis 13 (2.3) 10 (1.3) 0.54 (0.23‐1.24) .144 … …
Pallor 262 (47.0) 166 (21.1) 0.30 (0.24‐0.38) <.001 … …
Jaundice 27 (4.9) 8 (1.0) 0.20 (0.09‐0.45) <.001 … …
Diarrhea 58 (10.4) 29 (3.7) 0.33 (0.21‐0.52) <.001 0.29 (0.14‐0.63) .002
Feeding difficulty 194 (34.8) 161 (20.4) 0.48 (0.38‐0.61) <.001 0.59 (0.38‐0.90) .015
Seizures 130 (23.3) 50 (6.4) 0.22 (0.16‐0.31) <.001 0.26 (0.15‐0.44) <.001
Confusion or lethargy 109 (19.6) 63 (8.0) 0.36 (0.26‐0.50) <.001 0.47 (0.27‐0.84) .011
Unconscious or barely conscious 80 (14.4) 34 (4.3) 0.27 (0.18‐0.41) <.001 … …
Signs of shock 10 (1.8) 3 (0.4) 0.21 (0.06‐0.76) .018 … …
Severe dehydration 24 (4.3) 10 (1.3) 0.29 (0.14‐0.60) .001 0.09 (0.01‐0.53) .008
Mean temperature, (SD) °C 37.9 (1.2) 37.6 (1.1) 0.78 (0.70‐0.86) <.001 0.78 (0.66‐0.92) .003
Mean heart rate, (SD) bpm 145 (26) 146 (27) 1.00 (1.00‐1.01) .620 … …
Mean respiratory rate, (SD) bpm 53 (16) 59 (17) 1.02 (1.02‐1.03) <.001 … …
Median SpO2, % (IQR) 94 (86‐98) 90 (81‐96) 0.99 (0.98‐0.99) <.001 … …
Hypoxemia, SpO2 < 90% 149/472 (31.6) 337/
698 (48.3)
2.02 (1.58‐2.58) <.001 2.01 (0.37‐2.96) <.001
Investigations
PCV performed 497 (89.2) 682 (86.6) 0.78 (0.55‐1.09) .142 … …
Anemia 353 (71.0) 360 (52.8) 0.46 (0.36‐0.58) <.001 … …
Severe anemia 89 (17.9) 13 (1.9) 0.09 (0.05‐0.16) <.001 0.20 (0.09‐0.45) <.001
Mean PCV, % (SD) 25.0 (9.6) 30.5 (6.2) 1.09 (1.07‐1.11) <.001 … …
Malaria test done 410 (73.6) 589 (74.8) 1.06 (0.83‐1.36) .638 … …
RDT 220 (39.5) 306 (38.8) 0.97 (0.78‐1.21) .806 … …
Microscopy 190 (34.1) 286 (36.3) 1.10 (0.88‐1.38) .410 … …
Malaria test positive 252 (61.5) 202 (34.3) 0.33 (0.25‐0.43) <.001 0.49 (0.34‐0.71) <.001
RDT 125 (56.8) 76 (24.8) 0.25 (0.17‐0.36) <.001 … …
Microscopy 127 (66.8) 127 (44.4) 0.40 (0.27‐0.58) <.001 … …
HIV test done 247 (44.3) 257 (32.6) 0.61 (0.49‐0.76) <.001 … …
HIV‐positive 7 (2.8) 10 (3.9) 1.39 (0.52‐3.71) .513 … …
CXR performed 22 (4.0) 118 (15.0) 4.28 (2.68‐6.85) <.001 … …
CXR positivec 13/14 (92.9) 82/101 (81.2) Not applicable
Other admission diagnoses
Malaria 349 (64.3) 217 (26.8) 0.31 (0.27‐0.36) <.001 Not applicable
Diarrhea 62 (11.4) 26 (3.3) 0.26 (0.17‐0.42) <.001 Not applicable
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4.1 | Do some clinical signs and tests skew
pneumonia diagnostic practices?
The case‐management approach to pneumonia, using clinical case
definitions, has been extremely important in improving the diagnosis,
treatment, and outcomes for children with pneumonia.6 However,
the clinical signs of pneumonia (cough and difficult or fast breathing)
are nonspecific and can overlap with other diseases that require
different treatment (eg, HIV, tuberculosis, malaria).6 The challenge of
overlapping diagnoses is particularly challenging in malaria‐endemic
regions, where failure to identify pneumonia as a comorbid or al-
ternate diagnoses may result in delayed or undertreatment.5,7,20,21
We found that the majority (325/557, 58%) of children with “mis-
sed” severe pneumonia had signs of severe respiratory distress (240/
557, 43.1%) or hypoxemia (149/472, 31.6%), suggesting substantial
respiratory compromise. These results are consistent with other recent
studies from large hospitals in Africa reporting similar hypoxemia pre-
valence in hospitalized children (aged <5 years) with pneumonia
(28‐49%).22‐26 We found that hypoxemia and severe respiratory dis-
tress were the strongest predictors of “detected” severe pneumonia
(aOR 3.87; 2.58‐5.79, P < .001 | aOR 2.01; 0.37‐2.96, P < .001).
Conversely, positive malaria testing or detection of severe ane-
mia were associated with lower likelihood of a pneumonia diagnosis
(aOR 0.49; 0.34‐0.71, P < .001 | aOR 0.20; 0.09‐0.45, P < .001). These
findings suggest that doctors had a lower index of suspicion for
pneumonia in children that did not exhibit obvious respiratory signs,
or who tested positive for other conditions. While this may be ap-
propriate, it does raise the question of whether bedside testing for
malaria and anemia contributed to missed pneumonia diagnoses.
Importantly, the routine use of pulse oximetry in participating hos-
pitals is atypical for many hospitals in low‐ and middle‐income
countries, and diagnostic practices may be different where pulse
oximetry is not used routinely.14,27
4.2 | Does lack of a pneumonia diagnosis
compromise care and outcomes?
Without any “gold standard” testing for pneumonia (and low use of
chest X‐ray radiography in participating hospitals), it is possible that
some children included in our study had other primary diagnoses and
were therefore not diagnosed with pneumonia. We found that two‐
thirds (261/389, 67.1%) of children with WHO‐defined severe
pneumonia were diagnosed with a different respiratory or systemic
condition that may mimic severe pneumonia: sepsis (205, 37.8%);
meningitis/encephalitis (28, 5.2%); or asthma (33, 6.1%).
TABLE 3 (Continued)
WHO severe pneumonia Odds ratio: detected severe pneumonia
Characteristic
“Potential
missed” diagnosis
“Detected”
diagnosis OR (95% CI) Pa aOR (95% CI)b P
Sepsis 205 (37.8) 103 (13.1) 0.25 (0.19‐0.32) <.001 Not applicable
Seizures 66 (12.2) 23 (2.9) 0.22 (0.13‐0.35) <.001 Not applicable
Haemoglobinopathy 16 (3.0) 6 (0.8) 0.25 (0.10‐0.65) .004 Not applicable
Meningitis/encephalitis 28 (5.2) 8 (1.0) 0.19 (0.09‐0.42) <.001 Not applicable
Severe acute malnutrition 24 (4.4) 9 (1.1) 0.25 (0.12‐0.54) <.001 Not applicable
Asthma 33 (6.1) 19 (2.4) 0.38 (0.21‐0.68) .001 Not applicable
Treatment
Parenteral antibiotic on day 1 472 (85.4) 751 (95.9) 4.03 (2.63‐6.16) <.001 Not applicable
IV Fluids 419 (75.8) 520 (66.4) 0.63 (0.50‐0.81) <.001 Not applicable
Outcome
Discharged well 423 (76.4) 628 (79.9) 1.23 (0.95‐1.60) .121 Not applicable
Died 68 (12.3) 72 (9.2) 0.72 (0.51‐1.02) .067 Not applicable
Discharged against medical advice 33 (6.0) 57 (7.3) 1.23 (0.79‐1.92) .352 Not applicable
Transferred to other facility 30 (5.4) 29 (3.7) 0.67 (0.40‐1.13) .132 Not applicable
Missing data 3 (0.5) 2 (0.3) 0.47 (0.08‐2.82) .409 Not applicable
Note: Number (%) unless otherwise indicated. Anemia = PCV < 32%. Died = died in hospital or palliated at home. Feeding difficulty = unable to breastfeed
or drink adequately. IQR = interquartile range, 25th to 50th centile. Severe anemia = PCV < 15%. Severe dehydration = sluggish capillary refill time (>3 s),
sunken eyes, decreased skin turgor. Severe pneumonia = cough or difficult breathing AND at least one of the following: severe respiratory distress;
hypoxemia (SpO2 < 90%); unable to breastfeed or drink adequately; decreased conscious state; seizures. Severe respiratory distress = severe chest
indrawing, grunting, gasping. Signs of shock = capillary refill < 3 s, weak pulse, low or unmeasurable blood pressure).
Abbreviations: PCV, packed cell volume (hematocrit); SD, standard deviation.
aP values derived from univariate logistic regression.
bAdjusted odds ratio derived from mixed effects logistic regression model that included random effects to adjust for clustering at the hospital level, and
used stepwise regression to select variables that were independently associated with ‘detected’ diagnosis at alpha 0.05 level (excluding treatment and
outcome variables).
cCXR denominator restricted to those with results available.
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TABLE 4 Associations with “detected” severe malaria diagnosis and presenting signs, treatments, and outcome
WHO severe malaria Odds ratio: detected severe malaria diagnosis
Characteristic
“Potential missed”
diagnosis
“Detected”
diagnosis OR (95% CI) Pa aOR (95% CI)b P
Participants (total) 365 (100) 1934 (100)
Infants 28 d to 1 y 85 (23.3) 254 (13.1) Reference …
Children 1‐4 y 189 (51.8) 1235 (63.9) 2.19 (1.64‐2.92) <.001
Children 5‐14 y 88 (24.1) 432 (22.3) 1.64 (1.17‐2.30) .004
Age unknown (missing) 3 (0.8) 13 (0.7) Not applicable
Sex, female (%) 43.7 44.4 0.97 (0.77‐1.22) .791 … …
Median age, mo (IQR) 27.3 (12.0‐58.0) 32.0 (18.0‐52.6) 1.00 (1.00‐1.00) .698 … …
Admission source: home vs other 332 (91.0) 1695 (88.2) 0.75 (0.51‐1.09) .134 … …
Hospital type: government vs other 196 (53.7) 1162 (60.1) 0.77 (0.62‐0.96) .023 … …
Median LOS, days (IQR) 4 (2‐5) 4 (2‐5) 1.01 (0.98‐1.04) .555 … …
Documented signs and symptoms
History of fever 342 (93.7) 1906 (98.6) 4.58 (2.61‐8.04) <.001 3.78 (1.98‐7.23) <.001
History of cough or difficult breathing 74 (20.3) 335 (17.3) 0.82 (0.62‐1.09) .177 0.71 (0.52‐0.97) .034
Severe respiratory distress 35 (9.6) 182 (9.4) 0.98 (0.67‐1.43) .915 0.60 (0.38‐0.93) .024
Central cyanosis 0 (0.0) 34 (1.8) Not applicable
Pallor 181 (49.6) 1135 (58.7) 1.44 (1.15‐1.81) .001 … …
Jaundice 24 (6.6) 130 (6.7) 1.02 (0.65‐1.61) .918 … …
Diarrhea 60 (16.4) 115 (6.0) 0.32 (0.23‐0.45) <.001 0.33 (0.21‐0.50) <.001
Feeding difficulty 69 (18.9) 478 (24.7) 1.41 (1.06‐1.87) .017 … …
Seizures 169 (46.3) 925 (47.8) 1.06 (0.85‐1.33) .592 … …
Confusion or lethargy 115 (31.5) 598 (30.9) 0.97 (0.76‐1.24) .824 … …
Unconscious or barely conscious 70 (19.2) 444 (23.0) 1.26 (0.95‐1.66) .113 … …
Signs of shock 1 (0.3) 15 (0.8) 2.85 (0.37‐21.61) .312 … …
Severe dehydration 28 (7.7) 40 (2.1) 0.25 (0.15‐0.42) <.001 0.40 (0.21‐0.74) .003
Mean temperature, Celsius (SD) 37.9 (1.1) 37.9 (1.1) 0.99 (0.90‐1.10) .899 … …
Mean heart rate, bpm (SD) 137.0 (26.6) 138.5 (26.1) 1.00 (1.00‐1.01) .305 … …
Mean respiratory rate, bpm (SD) 39.2 (14.0) 39.9 (12.8) 1.00 (1.00‐1.01) .322 … …
Median SpO2, IQR (%) 97 (92‐98) 97 (93‐98) 1.01 (1.00‐1.02) .178 … …
Hypoxemia, SpO2 < 90% 47/295 (15.9) 214/1559 (13.7) 0.84 (0.60‐1.18) .318 … …
Investigations
PCV performed 360 (98.6) 1901 (98.3) 0.80 (0.31‐2.06) .644 … …
Anemia 237 (65.8) 1514 (79.6) 2.03 (1.59‐2.59) <.001 1.84 (1.38‐2.45) <.001
Severe anemia 87 (24.2) 645 (33.9) 1.61 (1.24‐2.09) <.001 … …
Mean PCV, % (SD) 25.0 (10.1) 21.7 (9.7) 0.97 (0.96‐0.98) <.001 … …
Malaria test done 365 (100) 1934 (100) Not applicable
RDT 125 (34.3) 1101 (56.9) 2.54 (2.01‐3.21) <.001 … …
Microscopy 242 (66.3) 842 (43.5) 0.39 (0.31‐0.50) <.001 … …
Malaria test positive 365 (100) 1934 (100) Not applicable
RDT 125 (100) 1098 (99.7) Not applicable
Microscopy 240 (99.2) 838 (99.5) 1.75 (0.32‐9.59) .521 … …
HIV test done 166 (24.5) 780 (40.3) 0.81 (0.65‐1.01) .067 … …
HIV‐positive 4 (2.4) 3 (0.4) 0.16 (0.03‐0.71) .016 … …
CXR performed 2 (0.6) 10 (0.5) 0.94 (0.21‐4.32) .940 … …
CXR positivec 1/1 (100) 6/6 (100) Not applicable
Other admission diagnoses
Pneumonia 25 (7.0) 53 (2.8) 0.42 (0.27‐0.66) <.001 Not applicable
Diarrhea 56 (15.6) 134 (6.9) 0.40 (0.29‐0.56) <.001 Not applicable
Sepsis 91 (25.4) 549 (28.4) 1.16 (0.90‐1.50) <.251 Not applicable
Seizures 134 (37.4) 449 (23.2) 0.51 (0.40‐0.64) <.001 Not applicable
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Even if some of these cases could be explained by alternate di-
agnoses, in the absence of definitive testing, existing guidelines
suggest that all children meeting WHO clinical criteria for severe
pneumonia should receive treatment, including parenteral anti-
biotics.4,6 Our findings show relatively high antibiotic coverage rates
in both those with “detected” and “missed” severe pneumonia, sug-
gesting that doctors recognized them as having a severe infection
requiring antibiotics. However, there was a significant difference
between those with “missed” severe pneumonia compared with those
with “detected” severe pneumonia (85% vs 96%, OR, 4.03; 2.63‐6.16,
P < .001). This suggests there is room for improvement in prompt
antibiotic administration to all children meeting criteria for severe
pneumonia, and raises questions about whether other standards of
care for severe pneumonia may also have been lacking (eg, oxygen,
saturation monitoring).
While we observed a statistically nonsignificant but clinically
relevant association with lower mortality in those with “detected” vs
“missed” severe pneumonia (OR, 0.72; 0.51‐1.02, P = .067), we cannot
necessarily attribute this to diagnostic or treatment practices. The
“missed” severe pneumonia subgroup were more likely to have
neurological signs (eg, seizures, altered conscious state) and be given
a diagnosis of seizures, meningitis, or severe acute malnutrition—all
features that may be associated with poorer clinical outcomes. We
face similar challenges interpreting the lower mortality in those with
“detected” vs “missed” severe malaria.
4.3 | What is the pathophysiology behind
overlapping pneumonia and malaria syndromes?
While a large proportion of children diagnosed with pneumonia were
given a co‐diagnosis of malaria (567/1799, 32%), overlap was not so
obvious among those with WHO case definition severe pneumonia
and severe malaria (177/1345, 13%, of severe pneumonia cases also
met criteria for severe malaria). Previous studies have suggested that
while clinical presentation of malaria and pneumonia may overlap,
true severe disease overlap is uncommon, particularly in areas and
times of lower malaria transmission.5,21,28,29
The shared clinical features of severe pneumonia and severe
malaria include: fever; tachypnoea and respiratory distress; altered
conscious state. In severe pneumonia, respiratory distress is related
to the degree of lung injury, the age of the child (younger children
typically display more prominent respiratory signs), and the presence
of comorbid conditions (eg, malnutrition, anemia). Altered conscious
state typically reflects impaired cerebral oxygenation, related to
hypoxemia and/or impaired perfusion.
In severe malaria, respiratory distress is a relatively common
finding and is a well‐established predictor of mortality among chil-
dren with severe malaria, increasing their risk of death approximately
fourfold.30‐32 We observed a relatively high prevalence of hypoxemia
(261/1854, 14%) and severe respiratory distress (217/2299, 9%)
among children meeting WHO criteria for severe malaria. Data from
TABLE 4 (Continued)
WHO severe malaria Odds ratio: detected severe malaria diagnosis
Characteristic
“Potential missed”
diagnosis
“Detected”
diagnosis OR (95% CI) Pa aOR (95% CI)b P
Haemoglobinopathy 17 (4.8) 46 (2.4) 0.49 (0.28‐0.86) .014 Not applicable
Meningitis/encephalitis 30 (8.4) 161 (8.3) 0.99 (0.66‐1.49) .972 Not applicable
Severe acute malnutrition 13 (3.6) 24 (1.2) 0.33 (0.17‐0.66) .002 Not applicable
Asthma 0 (0.0) 0 (0.0) Not applicable Not applicable
Treatment
Parenteral antimalarial on day 1 302 (90.4) 1782 (92.4) 0.29 (0.87‐1.93) .209 Not applicable
IV fluids 363 (100) 1926 (99.8) Not applicable Not applicable
Outcome
Discharged well 304 (83.8) 1646 (85.6) 1.15 (0.85‐1.56) .374 Not applicable
Died 29 (8.0) 94 (4.9) 0.59 (0.38‐0.91) .017 Not applicable
Discharged against medical advice 24 (6.6) 142 (7.4) 1.13 (0.72‐1.76) .605 Not applicable
Transferred to other facility 6 (1.7) 42 (2.2) 1.33 (0.56‐3.15) .520 Not applicable
Missing data 2 (0.6) 10 (0.5) 0.94 (0.21‐4.32) .940 Not applicable
Note: Number (%) unless otherwise indicated. Anemia = PCV < 32%. Died = died in hospital or palliated at home. Feeding difficulty = unable to breastfeed
or drink adequately. IQR = interquartile range, 25th to 50th centile. Severe anemia = PCV < 15%. Severe dehydration = sluggish capillary refill time (>3 s),
sunken eyes, decreased skin turgor. Severe malaria = fever or history of fever AND positive malaria test AND at least one of the following: severe anemia;
decreased conscious state; seizures. Severe respiratory distress = severe chest indrawing, grunting, gasping. Signs of shock = capillary refill < 3 s, weak
pulse, low or unmeasurable blood pressure).
Abbreviations: PCV, packed cell volume (hematocrit); SD, standard deviation.
aP values derived from univariate logistic regression.
bAdjusted odds ratio derived from mixed effects logistic regression model that included random effects to adjust for clustering at the hospital level, and
used stepwise regression to select variables that were independently associated with “detected” diagnosis at alpha .05 level (excluding treatment and
outcome variables).
cCXR denominator restricted to those with results available.
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the multicentre AQUAMAT trial showed that 17% of children hos-
pitalized with severe malaria had signs of respiratory distress,32
while smaller studies have reported variable incidence between 14%
and 60%.31,33
In malaria, compensatory hyperventilation related to metabolic
acidosis is the most common driver of respiratory signs—causing
tachypnoea, chest indrawing, nasal flaring, and deep breathing—and
is probably the primary mechanism for excess mortality.30 Severe
anemia may similarly result in increased respiratory effort, particu-
larly if associated with cardiac failure. While anemia‐associated
cardiac failure is anecdotally common, limited data from one Kenyan
study reported mild to moderate cardiomegaly in 11% (7/64) of
children with malaria and severe anemia but no evidence of
pulmonary edema or congestion.5 Similar to previous studies, we
found very high incidence of severe anemia among children with
severe malaria (732/2261, 32%).5,28 We did not collect data on
cardiac failure.
Adult studies suggest that acute respiratory distress syndrome
(ARDS) is relatively common in severe malaria, noting that respiratory
symptoms may develop following treatment when malaria parasite
blood levels have dropped.34,35 This suggests that parasitic infiltration
into the lungs may not be the only cause of respiratory signs, and that
posttreatment inflammatory effects (perhaps immune‐mediated) may
be major contributors.34,35 However, ARDS is less common in children
with severe malaria and it is unclear how much parasitic sequestration
in child lungs contributes to respiratory signs.35
4.4 | How can frontline healthcare workers
disentangle severe pneumonia and malaria?
Previous studies in similar contexts have failed to find clinical or
laboratory signs that reliably distinguish between severe malaria and
pneumonia.5,28 In Mozambique, younger age, dehydration, lower PCV
counts, and hyperbilirubinaemia were predictive of severe malaria,
while preadmission antibiotic treatment, crackles, unilateral chest
signs, nasal flaring, hypoxemia, poorer nutritional status, and higher
leukocyte counts were predictive of severe pneumonia.28 In Kenya,
severe indrawing, unilateral chest signs, and hypoxemia were found
to be specific predictors of radiographic pulmonary consolidation, but
only crackles had reasonable specificity and sensitivity.5 Authors of
the papers from Mozambique and Kenya emphasized the inability of
any combination of signs to reliably distinguish between severe
pneumonia and malaria, and recommended that all hospitalized
children meeting criteria for severe pneumonia and malaria be
treated for both—especially in the absence of chest X‐ray radio-
graphy facilities.5,28
Our findings suggest that doctors were using signs of severe
respiratory distress and hypoxemia to diagnose pneumonia appro-
priately. However, doctors may have been overly reliant on these
insensitive respiratory signs and unduly influenced away from a
pneumonia diagnosis when other signs were present that could still
be consistent with severe pneumonia (eg, diarrhea, altered conscious
state, feeding difficulties)—or when bedside testing suggested an
additional diagnosis (eg, malaria, anemia). While the proportion of
“missed” severe malaria diagnoses was relatively low, our results
suggest that doctors appropriately used severe anemia as a predictor
of malaria diagnosis but may have been unduly swayed away from a
malaria diagnosis by other signs that could still be consistent with
severe malaria (eg, diarrhea, severe dehydration).
4.5 | Limitations
This study involved post hoc exploratory data analysis and is
therefore primarily hypothesis generating. We relied on docu-
mented clinical information and had minimal missing data, thanks
to the close attention of our research nurses at each site. A pe-
diatrician assessed the level of detail in case note documentation
before commencing data collection, but we did not independently
verify the documented clinical signs or diagnostic results. Where
clinical signs were not documented, we assumed that they were
not present; however, this may have resulted in an underestimate
of signs. We focussed comparative analysis on those meeting
WHO definitions of severe pneumonia and malaria to exclude
those with mild respiratory disease or incidental parasitaemia. We
were limited by the lack of independent confirmatory testings,
such as routine chest X‐ray radiography or blood cultures, which
could have more accurately defined severe pneumonia and in-
vasive bacterial disease.
While we did not exclude children with HIV from analysis, this
study was conducted in an area with low HIV‐prevalence and results
may not be generalizable to contexts with higher HIV prevalence.
Southwest Nigeria is relatively wealthier and better served with
health services and staff than other regions of Nigeria (and sub‐
Saharan Africa more broadly), and participating hospitals had re-
ceived particular assistance with pulse oximetry and oxygen therapy.
Diagnostic practices may be different in other areas of Nigeria and
Africa that have lower socioeconomic indices, fewer healthcare
workers, and less available hospital services. Routine use of pulse
oximetry by nurses in our study is relatively unusual for hospitals in
sub‐Saharan Africa,27 and may have influenced diagnostic treatment
practices.14
5 | CONCLUSIONS
Clinical overlap between children presenting with malaria and
pneumonia continues to present diagnostic challenge to healthcare
workers in Nigerian hospitals. Current diagnostic practices miss up to
half of severe pneumonia cases and may result in delayed or un-
dertreatment and poorer clinical outcomes. Severe malaria diagnoses
are less frequently missed, and antimalarial treatment coverage is
high. Healthcare workers should be encouraged to consider pneu-
monia in all severely unwell children with respiratory signs, even if
they are also treated for malaria or another condition.
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